首页> 外文期刊>Journal of the Chemical Society, Perkin Transactions 1 >Antitumour imidazotetrazines. Part 39. Synthesis of bis(imidazotetrazine)s with saturated spacer groups
【24h】

Antitumour imidazotetrazines. Part 39. Synthesis of bis(imidazotetrazine)s with saturated spacer groups

机译:抗肿瘤咪唑并四嗪类。第39部分:具有饱和间隔基的双(咪唑并四嗪)的合成

获取原文
获取原文并翻译 | 示例
           

摘要

Bis(imidazotetrazine)s (16), related in structure to the antitumour agents mitozolomide (1a) and temozolomide (1b), but linked through the N(3)-N(3') atoms of the imidazo[5,1-d][1,2,3,5]tetrazine ring-systems, are prepared by interaction of 5-diazoimidazole-4-carboxamide (8) and diisocyanates (15). The presence of the polymethylene linker with/without sulfur and oxygen heteroatoms does not substantially affect the acid stability, base-catalysed decomposition, antitumour activity or DNA base alkylation preference characteristic of the unlinked imidazotetrazines mitozolomide and temozolomide. [References: 28]
机译:Bis(咪唑并四嗪)(16),在结构上与抗肿瘤药线虫胺(1a)和替莫唑胺(1b)相关,但通过咪唑并[5,1-d]的N(3)-N(3')原子连接] [1,2,3,5]四嗪环系统是通过5-重氮咪唑-4-羧酰胺(8)和二异氰酸酯(15)的相互作用制备的。具有/不具有硫和氧杂原子的多亚甲基连接基的存在基本上不影响未连接的咪唑并四唑酮类咪唑胺和替莫唑胺的酸稳定性,碱催化的分解,抗肿瘤活性或DNA碱基烷基化偏好特性。 [参考:28]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号